ALTRAPHARMA Invest ApS: Financial statements 2024
CVR: 34483884
Source: annual report 2024, Danish Business Authority
01/07/2023 – 30/06/2024
ALTRAPHARMA Invest ApS (CVR 34483884) has filed annual accounts for 2024. In 2024, the company reported a gross profit of DKK -42,917 and a net result of DKK 86,556 compared with DKK -67,116 the year before. Equity in the 2024 report amounted to DKK 88,711. The solvency ratio was 37%.
- Gross Profit
- DKK -42,917
- Profit/Loss
- DKK 86,556
- Equity
- DKK 88,711
- Total Assets
- DKK 239,671
- Employees
- 0
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2024 | - | -43 t. | 87 t. | 89 t. | 0 |
| 2023 | - | -67 t. | -67 t. | 2 t. | 0 |
| 2022 | - | -172 t. | -484 t. | 69 t. | 1 |
| 2021 | - | -76 t. | -146 t. | 554 t. | 0 |
| 2020 | - | 527 t. | 407 t. | 699 t. | 0 |
Official annual report
Screen every Danish company
Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.
Try company screeningAbout ALTRAPHARMA Invest ApS
ALTRAPHARMA Invest ApS is a Danish company of the type Anpartsselskab based in Holte, founded in 2012. The company is registered under the industry Anden teknisk rådgivning. The company was previously named ALTRAPHARMA ApS. The management consists of Marianne Thrane. The company is owned by ALTRA 14 ApS and Juniwik Business Management AB. The company has 1 employee (2025). In 2025, the company reported a gross profit of DKK -88,915 and a net result of DKK -84,944 compared with DKK 86,556 the year before. Equity in the 2025 report amounted to DKK 103,766.